prevention of recurrent urinary tract infections in women

Comparison of cranberry pills and nitrofurantoin tablets on the prevention of relapse recurrent urinary tract infections in women.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015111625072N1

Enrollment

Registered

2015-12-02

Start date

2014-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent urinary tract infections. Other and unspecified infectious diseases

Interventions

Intervention 1: group1: cranberry 500 mg tablets for 6 months . Intervention 2: group2: received nitrofurantoin 100 mg during night for 6 months. Intervention 3: control group: received placebo fo

Treatment - Drugs

Placebo

group1: cranberry 500 mg tablets for 6 months .

group2: received nitrofurantoin 100 mg during night for 6 months

control group: received placebo for 6 months

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women 15-45 years old who suffer from cystitis Kashani hospital clinics were frequent. Exclusion criteria: those with anatomic abnormalities of the genitourinary system (stone,Ureterocele and hydronephrosis)? impaired functional genitourinary system (neurogenic bladder) Darshtnd.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Recurrent urinary tract infections. Timepoint: Every two months to six months. Method of measurement: Physical examination, clinical signs of cystitis, urine culture and urine analysis Urine.	—

Secondary

Measure	Time frame
Burning and frequent urination. Timepoint: Once every two months to six months. Method of measurement: Ask the patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoctor Majid Shirani

Shahrekord University Of Medical Sciences

Dadgar@skums.ac.ir+98 38 3333 0061

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026